Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5647621 | The Journal of Allergy and Clinical Immunology: In Practice | 2017 | 10 Pages |
Abstract
Guideline-based management of asthma focuses on disease severity and choosing the appropriate medical therapy to control symptoms and reduce the risk of exacerbations. However, irrespective of asthma severity and often despite optimal medical therapy, patients may experience acute exacerbations of symptoms and a loss of disease control. Asthma exacerbations are most commonly triggered by viral respiratory infections, particularly with human rhinovirus. Given the importance of these events to asthma morbidity and health care costs, we will review common inciting factors for asthma exacerbations and approaches to prevent and treat these events.
Keywords
FEV1ICSSABAAsthmaAllergyleukotriene antagonistAnticholinergicsLong-acting β-agonistShort-acting β2-agonistLong-acting β2-agonistsemergency departmentAsthma exacerbationTreatmentLABAanti-IgEViral infectionforced expiratory volume in 1 secondRhinovirusPreventionInhaled corticosteroidssystemic corticosteroids
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jamee R. MD, Stephen P. MD, PhD, William W. MD,